Global Humira Competitive Landscape Professional Research Report 2025
Description
Global Humira Competitive Landscape Professional Research Report 2025
Research Summary
Humira, or adalimumab, is a prescription medication classified as a tumor necrosis factor (TNF) inhibitor. It is widely used to treat various autoimmune conditions, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn＇s disease, ulcerative colitis, psoriasis, and juvenile idiopathic arthritis. Humira works by targeting and neutralizing TNF-alpha, a cytokine involved in inflammatory processes. By inhibiting TNF-alpha, Humira helps reduce inflammation and alleviate symptoms associated with autoimmune diseases. It is administered through subcutaneous injections and is often prescribed when other conventional treatments have proven ineffective. While Humira can be highly effective in managing autoimmune conditions, its use may be associated with certain side effects, and patients are typically monitored closely by healthcare providers during treatment.
According to DIResearch's in-depth investigation and research, the global Humira market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Humira include AbbVie, Eisai, Cadila Healthcare, Torrent Pharmaceuticals, Amgen, Boehringer Ingelheim etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Humira. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Humira market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Humira market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Humira industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Humira Include:
AbbVie
Eisai
Cadila Healthcare
Torrent Pharmaceuticals
Amgen
Boehringer Ingelheim
Humira Product Segment Include:
Humira Syringe
Humira Pen
Humira Product Application Include:
Ankylosing Spondylitis
Rheumatoid Arthritis
Crohn’s Disease
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Humira Industry PESTEL Analysis
Chapter 3: Global Humira Industry Porter’s Five Forces Analysis
Chapter 4: Global Humira Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Humira Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Humira Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Humira Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Humira Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Humira Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Humira Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Humira Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Humira Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Humira Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Humira Product by Type
- 1.2.1 Humira Syringe
- 1.2.2 Humira Pen
- 1.3 Humira Product by Application
- 1.3.1 Ankylosing Spondylitis
- 1.3.2 Rheumatoid Arthritis
- 1.3.3 Crohn’s Disease
- 1.3.4 Others
- 1.4 Global Humira Market Revenue and Sales Analysis
- 1.4.1 Global Humira Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Humira Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Humira Market Sales Price Trend Analysis (2020-2032)
- 1.5 Humira Industry Trends and Innovation
- 1.5.1 Humira Industry Trends and Innovation
- 1.5.2 Humira Market Drivers and Challenges
- 2 Humira Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Humira Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Humira Market Analysis by Regions
- 4.1 Humira Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Humira Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Humira Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Humira Revenue and Market Share Forecast by Region (2026-2032)
- 4.3 Global Humira Sales and Forecast Analysis (2020-2032)
- 4.3.1 Global Humira Sales and Market Share by Region (2020-2025)
- 4.3.2 Global Humira Sales Forecast by Region (2026-2032)
- 4.4 Global Humira Sales Price Trend Analysis (2020-2032)
- 5 Global Humira Market Size by Type and Application
- 5.1 Global Humira Market Size by Type
- 5.1.1 Global Humira Revenue and Forecast Analysis by Type (2020-2032)
- 5.1.2 Global Humira Sales and Forecast Analysis by Type (2020-2032)
- 5.2 Global Humira Market Size by Application
- 5.2.1 Global Humira Revenue and Forecast Analysis by Application (2020-2032)
- 5.2.2 Global Humira Sales and Forecast Analysis by Application (2020-2032)
- 6 North America
- 6.1 North America Humira Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Humira Market Size by Type
- 6.3.1 North America Humira Sales by Type (2020-2032)
- 6.3.2 North America Humira Revenue by Type (2020-2032)
- 6.4 North America Humira Market Size by Application
- 6.4.1 North America Humira Sales by Application (2020-2032)
- 6.4.2 North America Humira Revenue by Application (2020-2032)
- 6.5 North America Humira Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Humira Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Humira Market Size by Type
- 7.3.1 Europe Humira Sales by Type (2020-2032)
- 7.3.2 Europe Humira Revenue by Type (2020-2032)
- 7.4 Europe Humira Market Size by Application
- 7.4.1 Europe Humira Sales by Application (2020-2032)
- 7.4.2 Europe Humira Revenue by Application (2020-2032)
- 7.5 Europe Humira Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Humira Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Humira Market Size by Type
- 8.3.1 China Humira Sales by Type (2020-2032)
- 8.3.2 China Humira Revenue by Type (2020-2032)
- 8.4 China Humira Market Size by Application
- 8.4.1 China Humira Sales by Application (2020-2032)
- 8.4.2 China Humira Revenue by Application (2020-2032)
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Humira Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Humira Market Size by Type
- 9.3.1 APAC (excl. China) Humira Sales by Type (2020-2032)
- 9.3.2 APAC (excl. China) Humira Revenue by Type (2020-2032)
- 9.4 APAC (excl. China) Humira Market Size by Application
- 9.4.1 APAC (excl. China) Humira Sales by Application (2020-2032)
- 9.4.2 APAC (excl. China) Humira Revenue by Application (2020-2032)
- 9.5 APAC (excl. China) Humira Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Humira Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Humira Market Size by Type
- 10.3.1 Latin America Humira Sales by Type (2020-2032)
- 10.3.2 Latin America Humira Revenue by Type (2020-2032)
- 10.4 Latin America Humira Market Size by Application
- 10.4.1 Latin America Humira Sales by Application (2020-2032)
- 10.4.2 Latin America Humira Revenue by Application (2020-2032)
- 10.5 Latin America Humira Market Size by Country
- 10.6 Latin America Humira Market Size by Country
- 10.6.1 Mexico
- 10.6.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Humira Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Humira Market Size by Type
- 11.3.1 Middle East & Africa Humira Sales by Type (2020-2032)
- 11.3.2 Middle East & Africa Humira Revenue by Type (2020-2032)
- 11.4 Middle East & Africa Humira Market Size by Application
- 11.4.1 Middle East & Africa Humira Sales by Application (2020-2032)
- 11.4.2 Middle East & Africa Humira Revenue by Application (2020-2032)
- 11.5 Middle East Humira Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Humira Market Sales, Revenue and Price by Key Manufacturers (2021-2025)
- 12.1.1 Global Humira Market Sales by Key Manufacturers (2021-2025)
- 12.1.2 Global Humira Market Revenue by Key Manufacturers (2021-2025)
- 12.1.3 Global Humira Average Sales Price by Manufacturers (2021-2025)
- 12.2 Humira Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Humira Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 AbbVie
- 13.1.1 AbbVie Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 AbbVie Humira Product Portfolio
- 13.1.3 AbbVie Humira Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.2 Eisai
- 13.2.1 Eisai Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Eisai Humira Product Portfolio
- 13.2.3 Eisai Humira Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.3 Cadila Healthcare
- 13.3.1 Cadila Healthcare Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Cadila Healthcare Humira Product Portfolio
- 13.3.3 Cadila Healthcare Humira Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.4 Torrent Pharmaceuticals
- 13.4.1 Torrent Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Torrent Pharmaceuticals Humira Product Portfolio
- 13.4.3 Torrent Pharmaceuticals Humira Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.5 Amgen
- 13.5.1 Amgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Amgen Humira Product Portfolio
- 13.5.3 Amgen Humira Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.6 Boehringer Ingelheim
- 13.6.1 Boehringer Ingelheim Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Boehringer Ingelheim Humira Product Portfolio
- 13.6.3 Boehringer Ingelheim Humira Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Humira Industry Chain Analysis
- 14.2 Humira Industry Raw Material and Suppliers Analysis
- 14.2.1 Humira Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Humira Typical Downstream Customers
- 14.4 Humira Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
